Riskpilot← Back to searchSign inGet full accessNORAMIX LIAMYRANE 16 AS
ASActiveOrg 988009040Liamyrane 13, 5132 NyborgRental and operating of own or leased real estate · NACE 6820Est. 20050 employees
Revenue 2024
NOK 5,1M
+7% vs 2023
EBITDA margin
83.2%
+22% vs 2023
Equity ratio
81.6%
Financial strength
Net profit 2024
NOK 2,6M
+34% vs 2023
| Revenue | NOK 5,1M | +7% |
| EBITDA | NOK 4,2M | +22% |
| Net profit | NOK 2,6M | +34% |
| Total assets | NOK 30,4M | +2% |
| Equity | NOK 24,8M | +0% |
| Employees | 0 | — |
Legal name
NORAMIX LIAMYRANE 16 AS
Org number
988009040
Legal form
Aksjeselskap
NACE code
6820 · Rental and operating of own or leased real estate
Founded
16. mars 2005
Share capital
NOK 110 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Utleie av fast eiendom samt kjøp og salg av fast eiendom. Videre skal selskapet kunne kjøpe andeler i andre selskaper.
Address
Liamyrane 13, 5132 Nyborg
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 5 051 | 4 326 | 5 790 | 4 731 | 5 074 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | 4 257 | 3 370 | 4 688 | 3 465 | 4 220 |
| Depreciation & amort. | −919 | −944 | −944 | −944 | −946 |
| EBIT | 3 338 | 2 426 | 3 744 | 2 521 | 3 274 |
| Net financials | 108 | −158 | −124 | −25 | 82 |
| Profit before tax | 3 446 | 2 268 | 3 619 | 2 496 | 3 356 |
| Tax | 758 | 499 | 796 | 549 | 738 |
| Net profit | 2 688 | 1 769 | 2 823 | 1 947 | 2 618 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 34 707 | 37 138 | 30 923 | 29 836 | 30 372 |
| Equity | 24 996 | 25 004 | 24 964 | 24 879 | 24 776 |
| Long-term debt | 1 790 | 1 792 | 1 781 | 1 757 | 1 728 |
| Short-term debt | 7 922 | 10 342 | 4 178 | 3 199 | 3 867 |
| Total debt | 9 712 | 12 135 | 5 959 | 4 957 | 5 595 |
EBITDA margin
83.2%
This company
15.8%
Market median
+427% vs market
20202024
Equity ratio
81.6%
This company
38.2%
Market median
+114% vs market
20202024
Return on equity
10.6%
This company
18.4%
Market median
+42% vs market
20202024
Net profit margin
51.6%
This company
8.1%
Market median
+537% vs market
20202024
Asset turnover
0.17×
This company
1.12×
Market median
-85% vs market
20202024
Debt / equity
0.23×
This company
0.62×
Market median
+63% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
RE Deputy Member | Deputy Member | 2014 |
KR Chief Executive Officer | Chief Executive Officer | 2022 |
| Former (1) | ||
TE Chief Executive Officer | Chief Executive Officer | 2017 – 2022 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Noramix Invest AsNoramix Eiendom Holding AsNoramix Eiendom I As
NORAMIX LIAMYRANE 16 AS (this company)Board members of NORAMIX LIAMYRANE 16 AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Thomas Espeseth Rasmussen | Chief Executive Officer | 0 companies |
| Randi Elisabeth Kalvik Rasamanickam | Deputy Member | 0 companies |
| Keerthivarman Rasamanickam | Chief Executive Officer | 0 companies |